Cargando…
Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
BACKGROUND: Meta-analyses have identified serum levels of brain-derived neurotrophic factor (BDNF) as a potential biomarker for major depressive disorder (MDD). However, at the time, commercially available human ELISA kits are unable to distinguish between proBDNF (precursor of BDNF) and mature BDNF...
Autores principales: | Yoshida, Taisuke, Ishikawa, Masatomo, Niitsu, Tomihisa, Nakazato, Michiko, Watanabe, Hiroyuki, Shiraishi, Tetsuya, Shiina, Akihiro, Hashimoto, Tasuku, Kanahara, Nobuhisa, Hasegawa, Tadashi, Enohara, Masayo, Kimura, Atsushi, Iyo, Masaomi, Hashimoto, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411809/ https://www.ncbi.nlm.nih.gov/pubmed/22880079 http://dx.doi.org/10.1371/journal.pone.0042676 |
Ejemplares similares
-
Correction: Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2013) -
A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010) -
Treatment of refractory catatonic schizophrenia with low dose aripiprazole
por: Sasaki, Tsuyoshi, et al.
Publicado: (2012) -
Platelets Selectively Regulate the Release of BDNF, But Not That of Its Precursor Protein, proBDNF
por: Le Blanc, Jessica, et al.
Publicado: (2020) -
Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial
por: Hashimoto, Tasuku, et al.
Publicado: (2016)